iiinova — where your digital self keeps evolving

Reposted by Jordi Jornet-Plaza

Infosalut @infosalut.bsky.social · 20/03/2025

#PublicaSalutIB 🐀💊 @jordijornet.bsky.social , @sandracorvi.bsky.social i @garciafusterlab.bsky.social de @idisba.bsky.social han publicat la caracterització de l'ús terapèutic de la ketamina en rates adolescents www.infosalut.com/17236 doi.org/10.1016/j.biopha.2024.117781

024

Reposted by Jordi Jornet-Plaza

Julia Garcia-Fuster @garciafusterlab.bsky.social · 25/12/2024

Here is the link to "Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile": our latest publication with @jordijornet.bsky.social as first author: www.sciencedirect.com/science/arti...

sciencedirect.com

Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile

While ketamine was approved for treatment-resistant depression in adult patients, its efficacy and safety profile for adolescence still requires furth…

042

Reposted by Jordi Jornet-Plaza

Julia Garcia-Fuster @garciafusterlab.bsky.social · 22/12/2024

Celebrating a year full of accomplishments with these great bunch of people. Happy holidays 🙂

052